Murray Stahl's GSK Position Overview
Murray Stahl (via Horizon Kinetics Asset Management LLC) currently holds 25,365 shares of GSK plc (GSK) worth $1.09 M, representing 0.01% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Murray Stahl has maintained a strategic position in GSK, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 13,027 shares. Largest reduction occurred in Q3 2025, reducing 12,027 shares.
Analysis based on 13F filings available since 2013 Q2
Murray Stahl's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Murray Stahl
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2022 | +13,278 | New Buy | 13,278 | $29.45 |
| Q1 2023 | +9,560 | Add 72.00% | 22,838 | $35.58 |
| Q2 2023 | +1,000 | Add 4.38% | 23,838 | $35.64 |
| Q3 2023 | +1,100 | Add 4.61% | 24,938 | $36.25 |
| Q4 2023 | +227 | Add 0.91% | 25,165 | $37.06 |
| Q3 2024 | +13,027 | Add 51.77% | 38,192 | $40.88 |
| Q4 2024 | +1,673 | Add 4.38% | 39,865 | $33.82 |
| Q1 2025 | -1,200 | Reduce 3.01% | 38,665 | $38.74 |
| Q2 2025 | -1,273 | Reduce 3.29% | 37,392 | $38.40 |
| Q3 2025 | -12,027 | Reduce 32.16% | 25,365 | $43.16 |
Murray Stahl's GSK plc Investment FAQs
Murray Stahl first purchased GSK plc (GSK) in Q3 2022, acquiring 13,278 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl has held GSK plc (GSK) for 13 quarters since Q3 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl's largest addition to GSK plc (GSK) was in Q3 2022, adding 13,278 shares worth $391,000. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Murray Stahl's firm, Horizon Kinetics Asset Management LLC, owns 25,365 shares of GSK plc (GSK), valued at approximately $1.09 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, GSK plc (GSK) represents approximately 0.01% of Murray Stahl's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Murray Stahl's peak holding in GSK plc (GSK) was 39,865 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.